• Title of article

    Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinsonʹs disease

  • Author/Authors

    Jean-Pascal Lefaucheur، نويسنده , , Xavier Drouot، نويسنده , , Florian Von Raison، نويسنده , , Isabelle Ménard-Lefaucheur، نويسنده , , Pierre Cesaro، نويسنده , , Jean-Paul Nguyen، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2004
  • Pages
    12
  • From page
    2530
  • To page
    2541
  • Abstract
    Objective: To assess the effects of focal motor cortex stimulation on motor performance and cortical excitability in patients with Parkinsonʹs disease (PD). Methods: Repetitive transcranial magnetic stimulation (rTMS) was performed on the left motor cortical area corresponding to the right hand in 12 ‘off-drug’ patients with PD. The effects of subthreshold rTMS applied at 0.5 Hz (600 pulses) or at 10 Hz (2000 pulses) using a ‘real’ or a ‘sham’ coil were compared to those obtained by a single dose of l-dopa. The assessment included a clinical evaluation by the Unified Parkinsonʹs Disease Rating Scale and timed motor tasks, and a neurophysiological evaluation of cortical excitability by single- and paired-pulse TMS techniques. Results: ‘Real’ rTMS at 10 or 0.5 Hz, but not ‘sham’ stimulation, improved motor performance. High-frequency rTMS decreased rigidity and bradykinesia in the upper limb contralateral to the stimulation, while low-frequency rTMS reduced upper limb rigidity bilaterally and improved walking. Concomitantly, 10 Hz rTMS increased intracortical facilitation, while 0.5 Hz rTMS restored intracortical inhibition. Conclusions: Low- and high-frequency rTMS of the primary motor cortex lead to significant but differential changes in patients with PD both on clinical and electrophysiological grounds. The effects on cortical excitability were opposite to previous observations made in healthy subjects, suggesting a reversed balance of cortical excitability in patients with PD compared to normals. However, the underlying mechanisms of these changes remain to determine, as well as the relationship with clinical presentation and response to l-dopa therapy. Significance: The present study gives some clues to appraise the role of the primary motor cortex in PD. Clinical improvement induced by rTMS was too short-lasting to consider therapeutic application, but these results support the perspective of the primary motor cortex as a possible target for neuromodulation in PD.
  • Keywords
    Intracortical facilitation , Cortical excitability , Intracortical inhibition , Motor evoked potentials , Silent period
  • Journal title
    Clinical Neurophysiology
  • Serial Year
    2004
  • Journal title
    Clinical Neurophysiology
  • Record number

    523134